March 29, 2017 10:32 PM ET

Pharmaceuticals

Company Overview of G. Pohl-Boskamp GmbH & Co. KG

Company Overview

G. Pohl-Boskamp GmbH & Co. KG manufactures and supplies pharmaceutical products and medical devices to customers in Germany and internationally. It offers its products for therapeutic areas, such as respiratory system, parasites, urinary tract, cardiovascular system, gastrointestinal tract, sedation/sleep, and skin. G. Pohl-Boskamp GmbH & Co. KG was founded in 1835 and is based in Hohenlockstedt, Germany.

Kieler Straße 11

Hohenlockstedt,  25551

Germany

Founded in 1835

Phone:

49 4826 59 0

Fax:

49 4826 59 109

Key Executives for G. Pohl-Boskamp GmbH & Co. KG

Chief Executive Officer and General Manager
General Manager
General Manager
General Manager
General Manager
Compensation as of Fiscal Year 2016.

G. Pohl-Boskamp GmbH & Co. KG Key Developments

Pohl-Boskamp Launches Myrtol(R) 300 in U.S

Pohl-Boskamp launched Myrtol(R) 300 in the U.S. Myrtol® 300, a cough/cold and respiratory health supplement, is launching in the United States. Composed of plant-derived essential oils, Myrtol® 300 is used to help fight cough and cold symptoms related to lung and sinus congestion. The supplement helps loosen mucus and makes it easier to cough and expel irritants in the airways, while also helping reduce cough frequency and inflammation. It has been tested in over 27 clinical trials and is clinically proven to help clear and maintain a healthy respiratory tract. Myrtol® 300 is clinically proven to help support: Respiratory health; Sinus and lung function; Healthy mucus production.

Espero Pharmaceuticals Announces Promotion of Nitrolingual Pumpspray (Nitroglycerin Lingual Spray) with G. Pohl-Boskamp GmbH & Co. KG and Jacksonville Pharmaceuticals

Espero Pharmaceuticals, Inc. assumed the U.S. promotional responsibility for Nitrolingual Pumpspray, in an exclusive licensing agreement with G. Pohl-Boskamp GmbH & Co. KG. Jacksonville Pharmaceuticals has also assumed distribution and supply responsibility for the authorized generic version of Nitrolingual Pumpspray. Nitrolingual Pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. In November 2015, Espero Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for its nitroglycerin sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. The FDA has set an action date of June 10, 2016 to complete its review, as per the Prescription Drug User Fee Act.

Navamedic Expands Cooperation Agreement with Pohl-Boskamp

Navamedic ASA announced an expanded cooperation agreement with Pohl-Boskamp, for distribution of Nitrolingual- Pumpspray in the Nordic markets. Nitrolingual- Pumpspray is an oral spray of nitroglycerine used for relief or prevention of sudden attacks of chest pain associated with angina pectoris caused by heart disease. Annual sales of Nitrolingual- in the Nordic markets are expected to be around NOK 8 million. Navamedic has distributed several Pohl-Boskamp products in the Nordic markets since 2014, including NYDA- head lice treatment and GeloRevoice- throat lozenges, which are now available at more than 1,400 pharmacies across the Nordic region.

Similar Private Companies By Industry

Company Name Region
3B Pharmaceuticals GmbH Europe
Accelsiors Group International Europe
Aenova Group GmbH Europe
Aenova Holding GmbH Europe
AiCuris GmbH & Co. KG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact G. Pohl-Boskamp GmbH & Co. KG, please visit www.pohl-boskamp.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.